Mozambique Selisistat chemical structure has recently released nationwide community prevalence survey data suggesting pockets of high HIV prevalence in central and southern Mozambique . The Manhiça study area is likely to be representative of other semi-rural Mozambican populations with intensive migration to and from high HIV prevalence areas in South Africa, and thus the findings are not generalizable to all areas of the country. Despite the evidence suggesting that a plateau has been reached in HIV incidence
in Manhiça, the incidence among pregnant women remains unacceptably high from a public health standpoint. Many factors may contribute to this high HIV incidence, including migration, a high prevalence of sexually transmitted infections, high numbers of concurrent sexual partnerships and insufficient health care services. There is an urgent need for the current HIV prevention and treatment programmes to be expanded and for
access to them to be improved. We are grateful to all the women who participated in the studies, thus allowing this analysis to be carried out. Financial support for the prevalence studies was provided by the Institut Català d’Oncologia (Barcelona), Hospital buy BIBF 1120 Clinic (Barcelona), the CISM (Mozambique), which receives core funding from the Spanish Agency for InternationalCooperation (AECI) and the Spanish Fondo de Investigación Sanitaria (FIS01/1236; PI070233), the Banco de Bilbao, Vizcaya, and the Argentaria Foundation (grant number BBVA 02–0). The VCT clinic and day hospital receives core funding from the Agencia Catalana de Cooperacio al Desenvolupament.
D.N. was supported by either a grant from the Spanish Ministry of Education and Science (Ramon y Cajal). S.P.H was partially financed by the EU-FP7 Pregvax Project. “
“Acquired immune deficiency appears to be associated with serious non-AIDS (SNA)-defining conditions such as cardiovascular disease, liver and renal insufficiency and non-AIDS-related malignancies. We analysed the incidence of, and factors associated with, several SNA events in the LATINA retrospective cohort. Cases of SNA events were recorded among cohort patients. Three controls were selected for each case from cohort members at risk. Conditional logistic models were fitted to estimate the effect of traditional risk factors as well as HIV-associated factors on non-AIDS-defining conditions. Among 6007 patients in follow-up, 130 had an SNA event (0.86 events/100 person-years of follow-up) and were defined as cases (40 with cardiovascular events, 54 with serious liver failure, 35 with non-AIDS-defining malignancies and two with renal insufficiency). Risk factors such as diabetes, hepatitis B and C virus coinfections and alcohol abuse showed an association with events, as expected.